Ultra-low doses of rituximab for continued treatment of rheumatoid arthritis (REDO study): a randomised controlled non-inferiority trial
| Autor: | Verhoef, Lise M *, den Broeder, Nathan, Thurlings, Rogier M, van der Laan, Willemijn H, van der Weele, Wilfred, Kok, Marc R, Bernelot Moens, Hein J, Woodworth, Thasia G, van den Bemt, Bart J F, van den Hoogen, Frank H J, den Broeder, Alfons A |
|---|---|
| Zdroj: | In The Lancet Rheumatology November 2019 1(3):e145-e153 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|